Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Tecfidera
Tecfidera
As Tecfidera lags, Biogen hopes real-world data can help keep patients on their meds
Fierce Pharma
Mon, 09/19/16 - 09:54 am
Biogen
Tecfidera
MS
multiple sclerosis
Biogen reports positive new data for multiple sclerosis treatment
Marketwatch
Wed, 09/14/16 - 09:13 am
Biogen
MS
multiple sclerosis
Tecfidera
Biogen Inc MS Drugs: Deadly Cash Cows?
Bidness, ETC
Fri, 08/5/16 - 11:28 am
Biogen
MS
multiple sclerosis
Tecfidera
Avonex
Tysabri
Plegridy
Biogen Needs To Fill Pipeline Or Rethink Strategy
Seeking Alpha
Mon, 07/25/16 - 10:08 am
Biogen
Tecfidera
George Scangos
Biogen ends Tecfidera campaign, citing prescriptions
Medical Marketing and Media
Thu, 07/21/16 - 09:09 pm
Biogen
Tecfidera
drug ads
MS
multiple sclerosis
Payers keep squeezing MS drugmakers--and they may just take their tactics elsewhere
Fierce Pharma
Wed, 06/22/16 - 07:08 pm
MS
multiple sclerosis
payers
Sanofi
Aubagio
Teva Pharmaceutical
Copaxone
Biogen
Tecfidera
Avonex
Biogen profit beats on higher Tecfidera sales
Yahoo/Reuters
Thu, 04/21/16 - 08:47 am
Biogen
earnings
Tecfidera
Biogen's Newer Problems; Their Relevance To The Biotech Sector
Seeking Alpha
Mon, 03/28/16 - 09:22 pm
Biogen
Tecfidera
Merck
Ionis Pharmaceuticals
Gilead Sciences
Amgen
Regeneron
Patent Troubles Hit Biogen After Gilead, Regeneron; What’s Next?
Bidness, ETC
Fri, 03/25/16 - 09:39 am
Biogen
Gilead
Regeneron
patents
Tecfidera
Harvoni
Sovaldi
Biogen’s Best-Selling Drug Loses Patent In EU, Says Cowen
Investors.com
Fri, 03/11/16 - 09:37 am
Biogen
patents
Europe
Tecfidera
MS
multiple sclerosis
New rivals, formulary squeeze pose a double threat to Biogen MS sales
Fierce Pharma
Mon, 03/7/16 - 10:04 pm
Biogen
formulary
MS
multiple sclerosis
Roche
ocrelizumab
Tecfidera
Sanofi Chipping Away At Biogen's MS Dominance
Investors.com
Mon, 11/30/15 - 06:45 pm
Sanofi
Biogen
MS
multiple sclerosis
Aubagio
Tecfidera
Biogen to Cut 11% of Workforce, Multiple Sclerosis Drugs Sales Improve
TheStreet.com
Wed, 10/21/15 - 10:10 am
Biogen
earnings
restructuring
layoffs
Tecfidera
multiple sclerosis
Bad news for Biogen: Tecfidera sales trend flat in Q3, analyst says
Fierce Pharma Marketing
Wed, 09/16/15 - 10:00 am
Biogen
Tecfidera
MS
multiple sclerosis
Biogen patent survives challenge by hedge fund manager Kyle Bass
Yahoo/Reuters
Wed, 09/2/15 - 05:14 pm
Kyle Bass
Biogen
patents
Acorda Therapeutics
Tecfidera
Biogen's Tecfidera faces new challenge as scientists call for brain infection monitoring
Fierce Pharma
Fri, 08/7/15 - 05:41 pm
Biogen
Tecfidera
MS
multiple sclerosis
Biogen's comeback strategy after $18B market value loss: More acquisitions
BioPharma Dive
Mon, 07/27/15 - 11:13 am
Biogen
earnings
M&A
Tecfidera
Biogen loses $18B in market value, pulls down the rest of biotech with it
Bizjournals.com
Fri, 07/24/15 - 03:44 pm
Biogen
Tecfidera
earnings
Analyst: Biogen Will Miss On Tecfidera Sales; No Threat To Gilead's Harvoni
Yahoo/Benzinga
Fri, 04/24/15 - 10:35 am
Biogen
Tecfidera
Merck
Gilead Sciences
grazoprevir/elbasvir
Harvoni
hepatitis C
Should Biogen Be Afraid of This Upstart?
Investopedia
Mon, 04/13/15 - 10:02 pm
Biogen
Receptos
MS
multiple sclerosis
ozanimod
Tecfidera
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »